Abstract:Abstract Background As one of the most lethal cancers, pancreatic cancer has been characterized by abundant supportive tumor-stromal cell microenvironment. Although the advent of tumor-targeted immune checkpoint blockers has brought light to patients with other cancers, its clinical efficacy in pancreatic cancer has been greatly limited due to the protective stroma. Thus, it is urgent to find potential new targets and establish multi-regulatory networks to predict patient prognosis and improve treatment. Methods We followed a strategy based on mining the Cancer Genome Atlas (TCGA) database and ESTIMATE algorithm to obtain the immune scores and stromal scores. Differentially expressed genes (DEGs) associated with poor overall survival of pancreatic cancer were screened from a TCGA cohort. By comparing global gene expression with high vs. low immune scores and subsequent Kaplan–Meier analysis, DEGs that significantly correlated with poor overall survival of pancreatic cancer in TCGA cohort were extracted. After constructing the protein–protein interaction network using STRING and limiting the genes within the above DEGs, we utilized RAID 2.0, TRRUST v2 database and degree and betweenness analysis to obtain non-coding RNA (ncRNA)-pivotal nodes and transcription factor (TF)-pivotal nodes. Finally, multi-regulatory networks have been constructed and pivotal drugs with potential benefit for pancreatic cancer patients were obtained by screening in the DrugBank. Results In this study, we obtained 246 DEGs that significantly correlated with poor overall survival of pancreatic cancer in the TCGA cohort. With the advent of 38 ncRNA-pivotal nodes and 7 TF-pivotal nodes, the multi-factor regulatory networks were constructed based on the above pivotal nodes. Prognosis-related genes and factors such as HCAR3, PPY, RFWD2, WSPAR and Amcinonide were screened and investigated. Conclusion The multi-regulatory networks constructed in this study are not only beneficial to improve treatment and evaluate patient prognosis with pancreatic cancer, but also favorable for implementing early diagnosis and personalized treatment. It is suggested that these factors may play an essential role in the progression of pancreatic cancer.

CancerPro: Deciphering the Pan-Cancer Prognostic Landscape Through Combinatorial Enrichment Analysis and Knowledge Network Insights

CancerNet: a Database for Decoding Multilevel Molecular Interactions Across Diverse Cancer Types

The Transcriptomic Landscape of Prostate Cancer Development and Progression: an Integrative Analysis.

CancerProteome: a resource to functionally decipher the proteome landscape in cancer

Identification of Pan-Cancer Prognostic Biomarkers Through Integration of Multi-Omics Data

A network medicine approach for identifying diagnostic and prognostic biomarkers and exploring drug repurposing in human cancer

An Integrated Tool for Multi-Dimensional Cancer Research Utilizing Clinical Proteomic Tumor Analysis Consortium Data

CGPA: multi-context insights from the cancer gene prognosis atlas

Pan-Cancer Identification of Prognostic-Associated Metabolic Pathways

Identification of prognosis-related genes and construction of multi-regulatory networks in pancreatic cancer microenvironment by bioinformatics analysis

Pan-cancer proteogenomics connects oncogenic drivers to functional states

A Network Medicine Approach to Build a Comprehensive Atlas for the Prognosis of Human Cancer.

Proteomics, Pathway Array and Signaling Network-Based Medicine in Cancer

A pan-cancer analysis of prognostic genes.

Pan-cancer proteogenomics expands the landscape of therapeutic targets

PCAS: an Integrated Tool for Multi-Dimensional Cancer Research Utilizing Clinical Proteomic Tumor Analysis Consortium Data

Identifying Cancer Prognostic Modules by Module Network Analysis

Discovery of Pan-Cancer Related Genes Via Integrative Network Analysis.

Identification of Potential Key Genes for Pathogenesis and Prognosis in Prostate Cancer by Integrated Analysis of Gene Expression Profiles and the Cancer Genome Atlas.

Integrative Analysis Reveals Disease-Associated Genes and Biomarkers for Prostate Cancer Progression